Skip to content

Statistics on Vaccination Programmes in the Past 3 years

Statistics on Vaccination Programmes in the Past 3 years

The Government provides free or subsidised seasonal influenza vaccination and pneumococcal vaccination to eligible Hong Kong residents (target groups). The following statistics include those doses vaccinated to target groups under the Government Vaccination Programme (GVP), Vaccination Subsidy Scheme (VSS), and Seasonal Influenza Vaccination School Outreach (Free of Charge) Programme (SIVSOP) conducted by the Government. Vaccinations administered through other sectors are not included.

Seasonal Influenza Vaccination

The data pertains to target groups who received the vaccination under the Government Vaccination Programme (GVP), the Vaccination Subsidy Scheme (VSS) and the Seasonal Influenza Vaccination School Outreach (Free of Charge) Programme (SIVSOP).

Target group

Number of vaccine recipients (% of the persons in the target group)a

2020/21 2021/22 2022/23 (As at 19 Mar 2023)

Children of age 6 months to under 6 years

115,100 (38.2%) 107,400 (37.6%) 91,200 (37.1%)

Children of age 6 to under 12 years

220,300 (60.2%) 234,500 (65.8%) 209,200 (60.0%)

Children of age 12 to under 18 yearsb

N/A N/A 61,400 (19.0%)

Persons of age 50 to 64 years

222,000 (12.3%) 198,700 (11.2%) 312,600 (17.4%)

Persons of age 65 years or above

615,000 (44.7%) 578,700 (40.4%) 715,200 (47.1%)


122,300 97,300 108,600

 Only where accurate population statistics available for the group.

In 2022/23, eligible groups of Hong Kong residents are expanded to include those less than 18 years (or secondary school students) in various SIV programmes under the DH for this season.

Eligible pregnant women, persons with chronic medical problems, healthcare workers, poultry workers, pig farmers or pig-slaughtering industry personnel.

Pneumococcal Vaccination

The data below pertains to figures of pneumococcal vaccination for elderly of age 65 years or above under the Government Vaccination Programme and the Vaccination Subsidy Scheme. In 2016/17 season, the Programmes offered a single dose of free or subsidised 23-valent pneumococcal polysaccharide vaccine (23vPPV) to elderly. Starting from October 2017, the Programmes offered an additional dose of free or subsidized 13-valent pneumococcal conjugate vaccine (PCV13) to elderly who have high-risk conditions.


2021/22 2022/23
(as at 26 February 2023)

Number of vaccine# recipients

70,100^ 53,500* 61,500& 

Cumulative % among elderly population +

46.9% 42.4% 42.3%@

23vPPV or PCV13

^ Including 34 500 doses of 23vPPV and 35 600 doses of PCV13.

* Including 30 600 doses of 23vPPV and 22 900 doses of PCV13.

& Including 26 600 doses of 23vPPV and 24 800 doses of PCV13.

+ Refers to the cumulative percentage of surviving elderly, among elderly population, who had received at least a dose of 23vPPV or PCV13 under the programmes.

The relevant figures are calculated based on the accumulative number of persons vaccinated (excluding those deceased) as at 26 February 2023.